CELL INTELLIGENCE · 肿瘤细胞治疗研究

DNAM-1 刺激的 NK-92 细胞对激素非依赖性实体瘤细胞系表现出优先的细胞毒性和凋亡相关效应

DNAM-1-Stimulated NK-92 Cells Exert Preferential Cytotoxic and Apoptosis-Associated Effects on Hormone-Independent Solid Tumor Cell Lines.

非常规 T 细胞在泌尿系统肿瘤中：能抓住就抓住

Unconventional T cells in urological cancers: catch them if you can.

新型 PSCA 靶向衔接分子用于前列腺癌晚期 RevCAR-T 细胞治疗

Novel PSCA-Targeting Adapter Molecules for Late-Stage RevCAR-T Cell Therapy in Prostate Cancer.

男性性腺功能减退是否通过削弱免疫系统成为癌症危险因素？

Is Male Hypogonadism a Risk Factor for Cancer Through Weakening of the Immune System?

接受根治性大分割放疗的前列腺癌患者中的乳酸脱氢酶-5 与 TIL（肿瘤浸润淋巴细胞）

Lactate Dehydrogenase-5 and Tumor-Infiltrating Lymphocytes in Prostate Cancer Patients Undergoing Radical Hypofractionated Radiotherapy.

肿瘤微环境在介导放射性药物治疗中的作用：连接核医学与肿瘤免疫治疗

The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy.

将铁代谢、铁死亡与癌症联系起来：有效抗癌治疗干预的新靶点与前景

Linking Iron Metabolism, Ferroptosis, and Cancer: New Targets and Prospects for Effective Anticancer Therapeutic Interventions.

错配修复缺陷与程序性死亡配体 1 表达在初治高危和极高危局部晚期前列腺癌中的研究：组织形态学关联及预后价值

Mismatch Repair Deficiency and Programmed Death-Ligand 1 Expression in Treatment-Naïve High-Risk and Very High-Risk Locally Advanced Prostate Cancer:

双模态 PET/CT 与 PET/MRI 显像在多发性骨髓瘤/前列腺癌再分期及 BCMA 靶向 CAR-T 治疗疗效评估中的应用

Bimodal PET/CT and PET/MRI imaging in multiple myeloma/prostate cancer restaging and response to BCMA-targeted CAR T-therapy assessment.

前列腺癌细胞表面癌胚抗原：治疗潜力与放射性配体靶向

Cell surface oncofetal antigens in prostate cancer: therapeutic potential and radioligand targeting.

CEACAM5、Trop-2、5T4、GPC3 和 ROR1 癌胚蛋白在晚期前列腺癌中表达各异。针对这些蛋白的治疗药物和放射性药物显像剂正在研发中。尽管已出现令人振奋的发现，但仍需大量临床研究来确定靶向这些蛋白的价值。